Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biocept Inc (NQ: BIOC )

2.970 USD -0.050 (-1.66%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 24, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 366,661
Open 3.000
Bid (Size) 2.890 (1)
Ask (Size) 3.000 (1)
Prev. Close 3.020
Today's Range 2.700 - 3.060
52wk Range 2.980 - 8.380
Shares Outstanding 16,842,246
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Biocept Reports an Increase in COVID-19 RT-PCR Testing Volume with Spread of the Omicron Variant
Biocept has received more than 765,000 samples for RT-PCR COVID-19 testing since June 2020. 
From Business Wire News Releases
Biocept to Present at the H.C. Wainwright BioConnect Virtual Conference on January 10
Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces that Michael Nall, President and CEO, will present a company overview at the H.C.... 
From Business Wire News Releases

Performance

YTD
-25.19%
-25.19%
1 Month
-22.25%
-22.25%
3 Month
-22.25%
-22.25%
6 Month
-28.26%
-28.26%
1 Year
-54.66%
-54.66%

More News

Read More
Biocept’s CNSide Cerebrospinal Fluid Assay Identifies Actionable HER2 Mutations in Patients with Breast Cancer that has Metastasized to the Brain
From Business Wire News Releases
Biocept Launches Combined COVID-19 and Influenza Test to Provide Answers During Peak Flu Season
From Business Wire News Releases
CORRECTING and REPLACING Biocept’s CNSide Cerebrospinal Fluid Assay Aids in Monitoring Treatment Response and Detects Actionable Biomarkers in Patients with Metastatic Breast Cancer
From Business Wire News Releases
Biocept Reports Third Quarter 2021 Financial Results
From Business Wire News Releases
Study Shows Biocept’s Switch-Blocker Technology Enhances Performance of Conventional PCR-Based Liquid Biopsy Assays in Detecting Rare Cancer Mutations
From Business Wire News Releases
Biocept to Report Third Quarter 2021 Financial Results and Host Investor Conference Call on November 15, 2021
From Business Wire News Releases
Biocept to Present at the LD Micro Main Event on October 13
From Business Wire News Releases
Biocept Implements COVID-19 Testing Program at Select California Community Colleges, Supporting Testing Needs for Students and Staff Amid Pandemic
From Business Wire News Releases
Biocept to Present Data at RAS-Targeted Drug Development Summit Showing Ability of Its Switch-BlockerTM Technology to Detect Rare Cancer Mutations
From Business Wire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.